Cargando…

Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience

This study provides insight into the overall system performance, stability, and delivery accuracy of the first clinical self‐shielded stereotactic radiosurgery (SRS) system. Quality assurance procedures specifically developed for this unit are discussed, and trends and variations over the course of...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Shiv P., Sorensen, Stephen P., Jani, Shyam S., Yan, Xiangsheng, Pinnaduwage, Dilini S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018673/
https://www.ncbi.nlm.nih.gov/pubmed/36519493
http://dx.doi.org/10.1002/acm2.13857
_version_ 1784907862951067648
author Srivastava, Shiv P.
Sorensen, Stephen P.
Jani, Shyam S.
Yan, Xiangsheng
Pinnaduwage, Dilini S.
author_facet Srivastava, Shiv P.
Sorensen, Stephen P.
Jani, Shyam S.
Yan, Xiangsheng
Pinnaduwage, Dilini S.
author_sort Srivastava, Shiv P.
collection PubMed
description This study provides insight into the overall system performance, stability, and delivery accuracy of the first clinical self‐shielded stereotactic radiosurgery (SRS) system. Quality assurance procedures specifically developed for this unit are discussed, and trends and variations over the course of 2‐years for beam constancy, targeting and dose delivery are presented. Absolute dose calibration for this 2.7 MV unit is performed to deliver 1 cGy/MU at d(max )= 7 mm at a source‐to‐axis‐distance (SAD) of 450 mm for a 25 mm collimator. Output measurements were made with 2‐setups: a device that attaches to a fixed position on the couch (daily) and a spherical phantom that attaches to the collimating wheel (monthly). Beam energy was measured using a cylindrical acrylic phantom at depths of 100 (D(10)) and 200 (D(20)) mm. Beam profiles were evaluated using Gafchromic film and compared with TPS beam data. Accuracy in beam targeting was quantified with the Winston‐Lutz (WL) and end‐to‐end (E2E) tests. Delivery quality assurance (DQA) was performed prior to clinical treatments using Gafchromic EBT3/XD film. Net cumulative output adjustments of 15% (pre‐clinical), 9% (1st year) and 3% (2nd year) were made. The mean output was 0.997 ± 0.010 cGy/MU (range: 0.960–1.046 cGy/MU) and 0.993 ± 0.029 cGy/MU (range: 0.884–1.065 cGy/MU) for measurements with the daily and monthly setups, respectively. The mean relative beam energy (D(10)/D(20)) was 0.998 ± 0.004 (range: 0.991–1.006). The mean total targeting error was 0.46 ± 0.17 mm (range: 0.06–0.98 mm) for the WL and 0.52 ± 0.28 mm (range: 0.11–1.27 mm) for the E2E tests. The average gamma pass rates for DQA measurements were 99.0% and 90.5% for 2%/2 mm and 2%/1 mm gamma criteria, respectively. This SRS unit meets tolerance limits recommended by TG‐135, MPPG 9a., and TG‐142 with a treatment delivery accuracy similar to what is achieved by other SRS systems.
format Online
Article
Text
id pubmed-10018673
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100186732023-03-17 Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience Srivastava, Shiv P. Sorensen, Stephen P. Jani, Shyam S. Yan, Xiangsheng Pinnaduwage, Dilini S. J Appl Clin Med Phys Radiation Oncology Physics This study provides insight into the overall system performance, stability, and delivery accuracy of the first clinical self‐shielded stereotactic radiosurgery (SRS) system. Quality assurance procedures specifically developed for this unit are discussed, and trends and variations over the course of 2‐years for beam constancy, targeting and dose delivery are presented. Absolute dose calibration for this 2.7 MV unit is performed to deliver 1 cGy/MU at d(max )= 7 mm at a source‐to‐axis‐distance (SAD) of 450 mm for a 25 mm collimator. Output measurements were made with 2‐setups: a device that attaches to a fixed position on the couch (daily) and a spherical phantom that attaches to the collimating wheel (monthly). Beam energy was measured using a cylindrical acrylic phantom at depths of 100 (D(10)) and 200 (D(20)) mm. Beam profiles were evaluated using Gafchromic film and compared with TPS beam data. Accuracy in beam targeting was quantified with the Winston‐Lutz (WL) and end‐to‐end (E2E) tests. Delivery quality assurance (DQA) was performed prior to clinical treatments using Gafchromic EBT3/XD film. Net cumulative output adjustments of 15% (pre‐clinical), 9% (1st year) and 3% (2nd year) were made. The mean output was 0.997 ± 0.010 cGy/MU (range: 0.960–1.046 cGy/MU) and 0.993 ± 0.029 cGy/MU (range: 0.884–1.065 cGy/MU) for measurements with the daily and monthly setups, respectively. The mean relative beam energy (D(10)/D(20)) was 0.998 ± 0.004 (range: 0.991–1.006). The mean total targeting error was 0.46 ± 0.17 mm (range: 0.06–0.98 mm) for the WL and 0.52 ± 0.28 mm (range: 0.11–1.27 mm) for the E2E tests. The average gamma pass rates for DQA measurements were 99.0% and 90.5% for 2%/2 mm and 2%/1 mm gamma criteria, respectively. This SRS unit meets tolerance limits recommended by TG‐135, MPPG 9a., and TG‐142 with a treatment delivery accuracy similar to what is achieved by other SRS systems. John Wiley and Sons Inc. 2022-12-15 /pmc/articles/PMC10018673/ /pubmed/36519493 http://dx.doi.org/10.1002/acm2.13857 Text en © 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Srivastava, Shiv P.
Sorensen, Stephen P.
Jani, Shyam S.
Yan, Xiangsheng
Pinnaduwage, Dilini S.
Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience
title Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience
title_full Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience
title_fullStr Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience
title_full_unstemmed Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience
title_short Machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: Initial 2‐year experience
title_sort machine performance and stability of the first clinical self‐shielded stereotactic radiosurgery system: initial 2‐year experience
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018673/
https://www.ncbi.nlm.nih.gov/pubmed/36519493
http://dx.doi.org/10.1002/acm2.13857
work_keys_str_mv AT srivastavashivp machineperformanceandstabilityofthefirstclinicalselfshieldedstereotacticradiosurgerysysteminitial2yearexperience
AT sorensenstephenp machineperformanceandstabilityofthefirstclinicalselfshieldedstereotacticradiosurgerysysteminitial2yearexperience
AT janishyams machineperformanceandstabilityofthefirstclinicalselfshieldedstereotacticradiosurgerysysteminitial2yearexperience
AT yanxiangsheng machineperformanceandstabilityofthefirstclinicalselfshieldedstereotacticradiosurgerysysteminitial2yearexperience
AT pinnaduwagedilinis machineperformanceandstabilityofthefirstclinicalselfshieldedstereotacticradiosurgerysysteminitial2yearexperience